Utah Medical Products stock analysis
Want to see UTMD full AI Analyst Report?
Utah Medical Products (UTMD) Stock Price & Analysis
UTMD Stock Chart & Stats
- Day’s Range
- $70.99 - $72.87
- 52-Week Range
- $53.66 - $76.89
- Previous Close
- $71.97
- Volume
- N/A
- Average Volume (3M)
- 37.04K
- Market Cap
- $206.19M
- Enterprise Value
- $150.46M
- Total Cash (Recent Filing)
- $85.20M
- Total Debt (Recent Filing)
- $180.00K
- Price to Earnings (P/E)
- 21.7
- Beta
- 0.41
- Next Earnings
- Feb 02, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- Dec 17, 2026
- Dividend Yield
- 1.71%
Bulls Say, Bears Say
Bulls Say
Balance Sheet Strength
Minimal leverage materially reduces financial risk and preserves flexibility to fund operations, acquisitions, dividends, or buybacks without a meaningful debt burden. Stable equity and healthy ROE further support resilience if operating conditions remain soft.
Cash Generation
Strong operating and free cash flow, with FCF closely tracking earnings, indicates that reported profitability converts into usable funds. This supports internally funded investment and shareholder returns, although the lower level than past years warrants monitoring.
Orion Acquisition
Orion broadens UTMD’s presence in a specialized UK and European niche, adds expected annual sales, and is expected to be immediately accretive. Integration through existing Femcare facilities may create overhead efficiencies and reinforce targeted expansion.
Bears Say
Revenue Contraction
Revenue has declined materially over several years, indicating that the core business is not currently expanding. Persistent top-line contraction can reduce operating leverage, constrain reinvestment, and make future earnings growth harder to sustain.
Lower Free Cash Flow
Although cash generation remains solid, FCF has fallen from prior levels, reducing internally generated funding capacity. The decline signals that the revenue and earnings slowdown is affecting cash economics and could limit the pace of future investment or distributions.
Earnings Moderation
Profitability remains high, but earnings and FCF have stepped down from prior peaks alongside shrinking sales. If this persists, strong margins alone may not prevent lower absolute earnings, reducing the company’s ability to compound cash generation.
Utah Medical Products News
UTMD FAQ
What was Utah Medical Products’s price range in the past 12 months?
What is Utah Medical Products’s market cap?
When is Utah Medical Products’s upcoming earnings report date?
How were Utah Medical Products’s earnings last quarter?
Is Utah Medical Products overvalued?
Does Utah Medical Products pay dividends?
What is Utah Medical Products’s EPS estimate?
How many shares outstanding does Utah Medical Products have?
What happened to Utah Medical Products’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Utah Medical Products?
What is the TipRanks Smart Score and how is it calculated?
Utah Medical Products Stock Smart Score
Company Description
Utah Medical Products
Utah Medical Products, Inc. (UTMD) is a healthcare technology company focused on the creation, production, and supply of medical devices for the healthcare sector. UTMD offers a comprehensive portfolio of medical devices primarily serving labor and delivery departments and neonatal intensive care units. Key offerings include fetal monitoring accessories, vacuum-assisted delivery systems, and other specialized tools for childbirth. For newborns, they provide respiratory hoods (DISPOSA-HOOD), umbilical vessel catheters (GESCO), silicone oral protection devices (PALA-NATE), and lumbar sampling kits (MYELO-NATE). Beyond maternity care, the company supplies blood pressure monitoring systems (DELTRAN PLUS), disposable peritoneal dialysis sets (DIALY-NATE), urinary drainage systems (URI-CATH), and feeding devices (NUTRI-CATH/NUTRI-LOK). They also manufacture HEMO-NATE disposable filters, various catheterization procedure trays, and DELTRAN disposable pressure transducers along with related accessories and molded parts. A substantial portion of UTMD's offerings targets women's health and gynecological interventions. This includes advanced electrosurgical solutions like the LETZ system for cervical lesion excision, paired with FINESSE+ generators and various specialized electrodes (loop, ball, needle), and FILTRESSE evacuators. They also provide laparoscopic instruments (Femcare line), including trocars and cannulae, alongside EPITOME and OptiMicro electrosurgical devices. Complementing these are products for surgical contraception (Filshie Clip), endoscopic irrigation (PATHFINDER PLUS), suprapubic catheterization, and urinary incontinence management (LIBERTY systems). Specialized tools for uterine assessment and sampling, such as the ENDOCURETTE and TVUS/HSG-Cath, as well as the LUMIN uterine manipulator for laparoscopic procedures, complete this extensive portfolio. UTMD's diverse product range serves various healthcare settings, including neonatal intensive care units, labor and delivery wards, women's health centers within hospitals, outpatient clinics, and physicians' offices. The company facilitates distribution through a combination of direct customer service and sales teams, independent consultants, and manufacturer representatives. Established in 1978, Utah Medical Products, Inc. maintains its headquarters in Midvale, Utah.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Kevin L. Cornwell
- Employees
- 146
- Website
- www.utahmed.com
- Address
- 7043 South 300 West, Midvale, UT, 84047-1048, US
Utah Medical Products (UTMD) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 9 | 5 | 8 |
| Technical Analysis | 2 | 5 | 3 |
| Moving Averages | 7 | 0 | 5 |











